ZELTIQ Aesthetics, Inc. ZLTQ, a medical technology company focused
on developing and commercializing products utilizing its proprietary
controlled-cooling technology platform, announced it successfully secured an
unopposed settlement and permanent injunction against Marco Hallerbach, MD,
doing business as Dr. Hallerbach & Associates. ZELTIQ first filed suit in
October 2012 with the United States District Court for the Middle District of
Florida, Tampa Division, against Dr. Hallerbach for false advertising, false
designation of origin, unfair competition, trademark infringement, and unfair
and deceptive trade practices.
ZELTIQ is the exclusive licensee of Cryolipolysis, the patented technology
behind the aesthetic procedure marketed as CoolSculpting®. Cryolipolysis is
the non-invasive cooling of adipose tissue to induce lipolysis – the breaking
down of fat cells – to reduce body fat without damage to other tissues.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in